Metastatic neuroblastoma managed by supralethal therapy and bone marrow reconstitution (BMRc). Results of a four-institution Children's Cancer Study Group pilot study.

Google Scholar
  • 1 January 1985
    • journal article
    • Vol. 175, 557-63
Abstract
No abstract available